Saved in:
Bibliographic Details
Main Authors: Vrbaški, S., Stanić, G., Molinelli, S., Bhattarai, M., Abadi, E., Ciocca, M., Samei, E.
Format: Preprint
Published: 2025
Subjects:
Online Access:https://arxiv.org/abs/2512.22026
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866912799398035456
author Vrbaški, S.
Stanić, G.
Molinelli, S.
Bhattarai, M.
Abadi, E.
Ciocca, M.
Samei, E.
author_facet Vrbaški, S.
Stanić, G.
Molinelli, S.
Bhattarai, M.
Abadi, E.
Ciocca, M.
Samei, E.
contents In this work, we proposed virtual imaging simulators as an alternative approach to experimental validation of beam range uncertainty in complex patient geometry using a computational model of a human head and a photon-counting CT scanner. We validate the accuracy of stopping power ratio (SPR) calculations using a conventional stoichiometric calibration approach and a prototype software, TissueXplorer. A validated CT simulator (DukeSim) was used to generate photon-counting CT projections of a computational head model, which were reconstructed with an open-source toolbox (ASTRA). The dose of 2 Gy was delivered through protons in a single fraction to target two different cases of nasal and brain tumors with a single lateral beam angle. Ground truth treatment plan was made directly on the computational head model using clinical treatment planning software (RayStation). This plan was then recalculated on the corresponding CT images for which SPR values were estimated using both the conventional method and the prototype software TissueXplorer. The mean percentage difference in estimating the stopping power ratio with TissueXplorer in all head tissues inside the scanned volume was 0.28%. Stopping power ratios obtained with this method showed smaller dose distribution differences from the ground truth plan than the conventional stoichiometric calibration method on the computational head model. Virtual imaging offers an alternative approach to validation of the SPR prediction from CT imaging, as well as its effect on the dose distribution and thus downstream clinical outcomes. According to this simulation study, software solutions that utilize spectral information, such as TissueXplorer, hold promise for more accurate prediction of the stopping power ratio than the conventional stoichiometric approach.
format Preprint
id arxiv_https___arxiv_org_abs_2512_22026
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan
Vrbaški, S.
Stanić, G.
Molinelli, S.
Bhattarai, M.
Abadi, E.
Ciocca, M.
Samei, E.
Medical Physics
In this work, we proposed virtual imaging simulators as an alternative approach to experimental validation of beam range uncertainty in complex patient geometry using a computational model of a human head and a photon-counting CT scanner. We validate the accuracy of stopping power ratio (SPR) calculations using a conventional stoichiometric calibration approach and a prototype software, TissueXplorer. A validated CT simulator (DukeSim) was used to generate photon-counting CT projections of a computational head model, which were reconstructed with an open-source toolbox (ASTRA). The dose of 2 Gy was delivered through protons in a single fraction to target two different cases of nasal and brain tumors with a single lateral beam angle. Ground truth treatment plan was made directly on the computational head model using clinical treatment planning software (RayStation). This plan was then recalculated on the corresponding CT images for which SPR values were estimated using both the conventional method and the prototype software TissueXplorer. The mean percentage difference in estimating the stopping power ratio with TissueXplorer in all head tissues inside the scanned volume was 0.28%. Stopping power ratios obtained with this method showed smaller dose distribution differences from the ground truth plan than the conventional stoichiometric calibration method on the computational head model. Virtual imaging offers an alternative approach to validation of the SPR prediction from CT imaging, as well as its effect on the dose distribution and thus downstream clinical outcomes. According to this simulation study, software solutions that utilize spectral information, such as TissueXplorer, hold promise for more accurate prediction of the stopping power ratio than the conventional stoichiometric approach.
title Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan
topic Medical Physics
url https://arxiv.org/abs/2512.22026